mannitol has been researched along with Neoplasms in 67 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 47 (70.15) | 18.7374 |
1990's | 4 (5.97) | 18.2507 |
2000's | 4 (5.97) | 29.6817 |
2010's | 12 (17.91) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kashiwase, Y; Minami, K; Miyano, K; Nonaka, M; Terawaki, K; Ueta, Y; Uezono, Y; Uzu, M; Yanagihara, K; Yokoyama, T | 1 |
Ahn, DH; Bekaii-Saab, T; Fowler, J; Kaumaya, PTP; Lustberg, M; Mortazavi, A; Overholser, J; Ramaswamy, B; Wei, L; Wesolowski, R; Wu, C | 1 |
Li, GY; Mi, YT; Shao, F; Xin, FZ; Yang, CG; Yang, DG; Yu, JX | 1 |
Bischoff, KM; Kriwong, S; Leathers, TD; Manitchotpisit, P; Price, NP; Tayeh, M; Teeraworawit, S; Watanapokasin, R; Watanapoksin, R | 1 |
Ammori, Y; Inoue, M; Ishihara, T; Kawa, K; Kondo, O; Koyama-Sato, M; Kuwae, Y; Nishikawa, M; Oji, Y; Oka, Y; Sawada, A; Sugiyama, H; Tsuboi, A; Yamada-Nakata, K; Yasui, M | 1 |
Böhm, S; Forssmann, U; Gallerani, E; Gnad-Vogt, U; Gross, S; Hess, D; Kaempgen, E; Knuth, A; Lennerz, V; Mach, N; Ochsenbein, A; von Boehmer, L; Woelfel, T | 1 |
Altorki, NK; Bender, A; Ferrara, CA; Gnjatic, S; Hoffmann, E; Jäger, E; Karbach, J; Neumann, A; Old, LJ; Weidmann, E; Yuan, J | 1 |
Chen, KC; Chiu, WT; Chuang, CM; Hsieh, CL; Peng, RY; Shih, CM; Wang, HE; Yang, MH | 1 |
Doki, Y; Hoffman, EW; Isobe, M; Iwatsuki, K; Kakimi, K; Kiura, K; Nakajima, J; Nakayama, E; Naomoto, Y; Oka, M; Old, LJ; Pan, L; Sato, E; Seto, Y; Shiraishi, K; Takigawa, N; Tsuji, K; Uenaka, A; Wada, H; Yamatsuji, T | 1 |
Berti, L; Fung, G; Lam, KS; Li, Y; Luo, J; Tseng, HP; Xiao, K; Xiao, W | 1 |
Balcerska, A; Lysiak-Szydlowska, W; Owczarzak, A; Sliwinska, A; Stachowicz-Stencel, T; Synakiewicz, A | 1 |
Aruga, A; Ohno, S; Okuyama, R; Sugiyama, H; Yamamoto, M | 1 |
Coleman, RL; Hannigan, EV; Lucci, JA; Santoso, JT; Schafer, I | 1 |
KELLNER, B; NEMETH, L | 1 |
ECKHARDT, S; HARTAI, F; MOLNAR, E; SELLEI, C | 1 |
ECKHARDT, A; HARTAI, F; MOLNAR, A; SELLEI, C | 1 |
ZULIK, R | 1 |
ECKHARDT, A; SELLEI, C | 1 |
BROWN, SS; HADDOW, A; TIMMIS, GM | 1 |
ECKHARDT, S; SELLEI, C | 3 |
BALO, J; BESZNYAK, I; JUHASZ, J; KENDREY, G | 3 |
NEMETH, E; RUBANYI, P; SZEKELY, J | 1 |
BARLOW, AM; LEEMING, JT; WILKINSON, JF | 1 |
EMBERGER, JM; GARY-BOBO, J; IZARN, P; POURQUIER, H; PUJOL, H | 1 |
ANTONI, F; HIDVEGI, EJ; LAPIS, K | 1 |
PELLET, H; VIALLIER, J | 1 |
WHITE, FR | 2 |
ECKHARDT, S; HORVATH, IP; INSTITORISZ, L; SELLEI, C | 1 |
GRAF, F; TAKACS NAGY, L | 1 |
GRAF, F; TAKACSI NAGY, L | 1 |
HORVATH, T; VARGHA, L | 1 |
DUKAT, EG; KJELLBERG, RN; MARK, VH; SOLOWAY, AH | 1 |
CHALMERS, TC; JICK, H; KAMM, DE; MORRISON, RS; SNYDER, JG | 1 |
CONNORS, TA; ELSON, LA; LEESE, CL | 1 |
CSANYI, E; HORVATH, P; INSTITORIS, L | 1 |
CSANYI, E; HORVATH, PI; INSTITORIS, L | 1 |
UJHAZY, V; WINKLER, A | 1 |
Antoch, G; Beyer, T; Debatin, JF; Goehde, SC; Hauth, E; Jentzen, W; Kanja, J; Kuehl, H; Lauenstein, TC; Schneemann, H | 1 |
Bolonakis, I; Cordopatis, P; Cornet, S; Galanis, A; Georgoulias, V; Kanellou, P; Kosmatopoulos, K; Kotsakis, A; Mavroudis, D; Menez, J; Miconnet, I; Myllaki, G; Nikoloudi, I; Niniraki, M; Spyropoulou, M | 1 |
Adams, S; Angiulli, A; Angiulli, F; Ayyoub, M; Bhardwaj, N; Cruz, CM; Escalon, JB; Hoffmann, EW; Jungbluth, AA; Mears, G; O'Neill, D; Old, LJ; Pan, L; Pavlick, A; Ritter, G; Souleimanian, NE; Tosello, V; Valmori, D; Venhaus, R; Vogel, SM | 1 |
Wang, QL | 1 |
Greaves, J; Holland, JF; Kappatos, DC; Roboz, J | 1 |
Chiuten, DF; Muggia, FM; Rozencweig, M; Von Hoff, DD | 1 |
Kaplan, BH; Vogl, SE; Wollner, D; Zaravinos, T | 1 |
Jones, GM; Parshad, R; Sanford, KK; Tarone, RE | 1 |
Bommer, JC; Spikes, JD | 1 |
Fortmeyer, HP; Glüsenkamp, KH; Jähde, E; Rajewsky, MF; Volk, T | 1 |
Helland, IB; Jørgensen, L; Klementsen, B | 1 |
Dana, R; Kachhwaha, VS | 1 |
Goldberg, RS; Krakoff, IH; Newman, RA | 1 |
Alberts, DS; Rainey, JM | 1 |
Cvitkovic, E; Gonzales-Vitale, JC; Hayes, DM; Sternberg, SS | 1 |
Cvitkovic, E; Golbey, RB; Hayes, DM; Helson, L; Krakoff, IH; Scheiner, E | 1 |
Cannon, L; Fox, K; Glick, J; Glover, D; Grabelsky, S; Weiler, C | 1 |
Ranney, DF | 1 |
Craft, AW; Eastham, EJ; Laker, MF; Pearson, AD; Pledger, JV | 1 |
Cirera, L; Gay, M; Huguet, J; Martí, M; Plá, R; Tomé, T | 1 |
Sellei, C; Szentkláray, J | 2 |
Eckhardt, S; Horváth, IP; Institóris, L; Kralovánszky, J; Sellei, C | 1 |
Seidenglanz, G | 1 |
Schaison, G | 1 |
3 review(s) available for mannitol and Neoplasms
Article | Year |
---|---|
[Cisplatin in the treatment of malignant tumors].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Kidney; Lung; Mannitol; Neoplasms | 1983 |
Clinical trials with the hexitol derivatives in the U.S.
Topics: Animals; Clinical Trials as Topic; Dianhydrogalactitol; Dogs; Humans; Kinetics; Mannitol; Mice; Mitobronitol; Mitolactol; Neoplasms; Sugar Alcohols | 1981 |
[Chemotherapy of malignant tumors. 44].
Topics: Adrenal Cortex Hormones; Alkylating Agents; Androgens; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Azirines; Carbamates; Colchicine; Dichlorodiphenyldichloroethane; Esters; Estrogens; Ethers, Cyclic; Ethylamines; Excitatory Amino Acid Antagonists; Folic Acid Antagonists; Heterocyclic Compounds; Hormones; Hydrazines; Mannitol; Neoplasms; Phytotherapy; Pipobroman; Plants, Medicinal; Plants, Toxic; Podophyllum; Purines; Pyrimidines; Sulfonic Acids; Triazines; Vinblastine; Vincristine | 1970 |
14 trial(s) available for mannitol and Neoplasms
Article | Year |
---|---|
Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; B-Lymphocytes; Cell Proliferation; Cohort Studies; Epitopes, B-Lymphocyte; Female; Humans; Immunization; Male; Mannitol; Maximum Tolerated Dose; Middle Aged; Neoplasms; Oleic Acids; Receptor, ErbB-2; Treatment Outcome; Tumor Cells, Cultured; Vaccines, Subunit | 2019 |
The impact of microbial immune enteral nutrition on the patients with acute radiation enteritis in bowel function and immune status.
Topics: Acute Disease; Aged; Calcitonin; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chromatography, High Pressure Liquid; Enteral Nutrition; Enteritis; Female; Fish Oils; Glutamine; Humans; Killer Cells, Natural; Lactulose; Male; Mannitol; Middle Aged; Neoplasms; Nutritional Status; Prealbumin; Probiotics; Protein Precursors; Serum Albumin | 2014 |
Feasibility of Cancer Immunotherapy with WT1 Peptide Vaccination for Solid and Hematological Malignancies in Children.
Topics: Adjuvants, Immunologic; Adolescent; Antineoplastic Agents; Cancer Vaccines; Child; Child, Preschool; Female; Flow Cytometry; Humans; Immunohistochemistry; Infant; Infant, Newborn; Male; Mannitol; Neoplasms; Oleic Acids; Peptides; Polymerase Chain Reaction; T-Lymphocytes, Cytotoxic; WT1 Proteins | 2016 |
Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers.
Topics: Adjuvants, Immunologic; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line; Humans; Mannitol; Neoplasms; Oleic Acids; Treatment Outcome; Vaccines, Subunit | 2016 |
A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.
Topics: Adult; Aged; Antigens; Antigens, Neoplasm; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Humans; Immunity, Humoral; Male; Mannitol; Membrane Proteins; Middle Aged; Neoplasms; Oleic Acids; Peptide Fragments; Picibanil; Treatment Outcome; Vaccines, Subunit | 2011 |
Phase I trial of Wilms' Tumor 1 (WT1) peptide vaccine with GM-CSF or CpG in patients with solid malignancy.
Topics: Adjuvants, Immunologic; Aged; Cancer Vaccines; CpG Islands; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunohistochemistry; Male; Mannitol; Middle Aged; Neoplasms; Oleic Acids; Oligonucleotides; Vaccines, Subunit; WT1 Proteins | 2012 |
Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Creatinine; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Infusions, Intravenous; Kidney Diseases; Mannitol; Metabolic Clearance Rate; Middle Aged; Neoplasms; Sodium Chloride | 2003 |
Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation.
Topics: Administration, Oral; Adult; Aged; Artifacts; Barium Sulfate; Blood Glucose; Contrast Media; Digestive System; Female; Fluorodeoxyglucose F18; Galactans; Humans; Image Enhancement; Male; Mannans; Mannitol; Middle Aged; Neoplasms; Phantoms, Imaging; Plant Gums; Polysaccharides; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
A phase I study of the optimized cryptic peptide TERT(572y) in patients with advanced malignancies.
Topics: Adjuvants, Immunologic; Aged; Amino Acid Sequence; Autoantigens; Cancer Vaccines; CD8-Positive T-Lymphocytes; Female; Humans; Immunotherapy; Male; Mannitol; Maximum Tolerated Dose; Middle Aged; Molecular Sequence Data; Neoplasms; Oleic Acids; Peptides; Telomerase | 2006 |
Clinical trials with the hexitol derivatives in the U.S.
Topics: Animals; Clinical Trials as Topic; Dianhydrogalactitol; Dogs; Humans; Kinetics; Mannitol; Mice; Mitobronitol; Mitolactol; Neoplasms; Sugar Alcohols | 1981 |
Comparison of oral and intravenous hydration and diuretic, choice for protecting cisplatin induced nephrotoxicity.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Diuretics, Osmotic; Fluid Therapy; Furosemide; Humans; Infusions, Intravenous; Kidney Diseases; Mannitol; Neoplasms | 1996 |
Clinical toxicologic and pharmacologic studies of gallium nitrate.
Topics: Anemia; Calcium; Clinical Trials as Topic; Diuresis; Gallium; Humans; Kidney; Mannitol; Neoplasms | 1979 |
Clinical trials of WR-2721 and cis-platinum.
Topics: Adult; Aged; Amifostine; Cisplatin; Diuresis; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Mannitol; Middle Aged; Neoplasms; Organothiophosphorus Compounds | 1989 |
Clinical and pharmacologic experience with dibromodulcitol (NSC-104800). A new antitumor agent.
Topics: Adult; Aged; Alcohols; Animals; Antineoplastic Agents; Bromine; Clinical Trials as Topic; Female; Hodgkin Disease; Humans; Leukemia; Male; Mannitol; Mice; Middle Aged; Neoplasms; Rats; Stereoisomerism | 1969 |
51 other study(ies) available for mannitol and Neoplasms
Article | Year |
---|---|
Modulation of synaptic inputs in magnocellular neurones in a rat model of cancer cachexia.
Topics: Angiotensin II; Animals; Cachexia; Cell Line, Tumor; Disease Models, Animal; Excitatory Postsynaptic Potentials; Male; Mannitol; Miniature Postsynaptic Potentials; Neoplasm Transplantation; Neoplasms; Neurons; Patch-Clamp Techniques; Rats; Supraoptic Nucleus | 2018 |
Aureobasidium pullulans as a source of liamocins (heavy oils) with anticancer activity.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Ascomycota; Bacteria; Biological Products; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiops; HeLa Cells; Humans; Mannitol; Molecular Structure; Neoplasms; Oils; Sugar Alcohols; Vero Cells | 2014 |
Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.
Topics: Antigens, Neoplasm; Breast Neoplasms; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Flow Cytometry; Humans; Immunotherapy; Mannitol; Melanoma; Membrane Proteins; Neoplasm Staging; Neoplasms; Oleic Acids; Oligodeoxyribonucleotides; Ovarian Neoplasms; Sarcoma; Vaccination | 2010 |
Modeling of the in vivo kinetics of antioxidants delineates suitable parameters for selecting potential antioxidant adjuvants for cancer therapy.
Topics: Animals; Antineoplastic Agents; Antioxidants; Carotenoids; Complementary Therapies; Computer Simulation; Dietary Supplements; Half-Life; Humans; Intestinal Absorption; Lycopene; Mannitol; Models, Biological; Neoplasms; Reactive Oxygen Species | 2010 |
Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols.
Topics: Boronic Acids; Catechols; Cell Line, Tumor; Drug Carriers; Fluorescence Resonance Energy Transfer; Glucose; Humans; Hydrogen-Ion Concentration; Mannitol; Micelles; Nanoparticles; Neoplasms; Paclitaxel | 2012 |
Association between intestinal and antioxidant barriers in children with cancer.
Topics: Adolescent; Antineoplastic Agents; Antioxidants; Case-Control Studies; Child; Child, Preschool; Erythrocytes; Female; Glutathione Peroxidase; Humans; Intestinal Absorption; Lactulose; Male; Mannitol; Neoplasms; Oxidative Stress; Permeability; Prospective Studies; Serum Albumin; Superoxide Dismutase; Young Adult | 2012 |
[Studies on the inhibiting effect of a new nitrogen mustard derivative, 1, 6-bis(beta-chloraethylamino)-1, 6-desoxy-D-mannitol dihydrochloride (BCM), on tumor growth].
Topics: Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1956 |
[Clinical studies on a cytostatic mannitol derivative (BCM)].
Topics: Biomedical Research; Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1956 |
[Clinical experiences with BCM (degranol) beta-bis-chlorethylamino-D-mannitoldichlorhydrate].
Topics: Mannitol; Mannomustine; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1958 |
[Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1958 |
[Clinical trials of mechlorethamine-N-oxide in therapy of tumors].
Topics: Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Oxides; Phenylalanine | 1958 |
Tumour-inhibiting action of 1 : 6-dimethanesulphonyl-D-mannitol.
Topics: Antineoplastic Agents; Busulfan; Humans; Mannitol; Neoplasms | 1958 |
Clinical observations with 1, 6-bis(beta-chloroethylamino)-1, 6-deoxy-D-mannitol dihydrochloride (BCM) in malignant diseases.
Topics: Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1958 |
Effect of 1, 6-di-(2-bromoethylamino)-1, 6-dideoxy-D-mannitol dihydrobromide on tumours of laboratory animals.
Topics: Animals; Animals, Laboratory; Mannitol; Mechlorethamine; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds | 1959 |
[Pre- and post-operative dosage of degranol in operable cancer patients].
Topics: Humans; Mannitol; Mannomustine; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Postoperative Period | 1959 |
Mannomustine in treatment of leukaemias, polycythaemia, and malignant disorders.
Topics: Leukemia; Mannitol; Mannomustine; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Polycythemia | 1959 |
[Clinical trials of a new nitrogen mustard, MX 101].
Topics: Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1960 |
Heterogeneity of tumour ribonucleic acid and the effect of 'degranol' on it.
Topics: Mannitol; Mannomustine; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; RNA | 1960 |
[Experimenttal studies on the tumor growth-inhibiting effect of DBM (R13) (1,6-bis(2-bromoethylamino)-1,6-desoxy-D-mannitol dihydrobromide)].
Topics: Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Research | 1960 |
[Action of 1,6-bis(2-bromoethylamino)-1,6-didesoxy-D-mannitol dihydrobromide on transplanted animal cancer].
Topics: Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1960 |
Tumour-inhibiting action of 1,6-di-(2-bromoethyl-amino)-1,6-dideoxy-D-mannitol dihydrobromide [(DBM (R13)].
Topics: Animals; Humans; Mannitol; Mechlorethamine; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds | 1959 |
Clinical results after 5 years of treatment of tumours and leukaemias with degranol (Mannomustine).
Topics: Humans; Leukemia; Mannitol; Mannomustine; Neoplasms | 1961 |
[Trial treatment of neoplastic diseases by 1,6-dibromomannitol].
Topics: Antineoplastic Agents; Humans; Leukemia; Leukemia, Myeloid; Mannitol; Mitobronitol; Neoplasms | 1963 |
Addendum to report on mannitol myleran (NSC-37538).
Topics: Busulfan; Humans; Mannitol; Neoplasms | 1962 |
Mannitol myleran.
Topics: Busulfan; Mannitol; Neoplasms; Neoplasms, Experimental | 1962 |
EFFECT OF 1,6-DIBROMO-1,6-DIDEOXY-D-MANNITOL ON CHRONIC GRANULOCYTIC LEUKEMIA.
Topics: Antineoplastic Agents; Hematopoiesis; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mannitol; Neoplasms | 1963 |
THE THERAPEUTIC VALUE OF 1,6-BIS-(BETA-MESYLOXYETHYLAMINO)-1,6-DIDESOXY-D-MANNITE DICHLORHYDRATE IN CLINICAL PRACTICE.
Topics: Antineoplastic Agents; Blood Platelets; Erythrocyte Count; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukocyte Count; Lymph Nodes; Lymphocytes; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mannitol; Neoplasms; Radiography, Thoracic; Sarcoma | 1964 |
[CLINICAL TESTING OF THE THERAPEUTIC EFFECT OF 1,6-BIS(2-MESYLOXYETHYLAMINO) 1,6-DIDESOXY-D-MANNITOL DI-HC1 (R 49)].
Topics: Antineoplastic Agents; Blood Cell Count; Blood Platelets; Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Leukopenia; Lymphadenitis; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mannitol; Mannomustine; Neoplasms; Radiography, Thoracic; Sarcoma; Thrombocytopenia; Toxicology | 1964 |
NEW METHANESULPHONYL SUGAR ALCOHOLS AND THEIR CYTOSTATIC ACTIVITY.
Topics: Alcohols; Animals; Antineoplastic Agents; Cytostatic Agents; Mannitol; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma; Sarcoma, Yoshida; Sugar Alcohols | 1964 |
CHEMOTHERAPY OF BRAIN TUMORS. I. TRANSPLANTED MURINE EPENDYMOBLASTOMAS.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Ependymoma; Mannitol; Melphalan; Mice; Neoplasms; Neoplasms, Experimental; Neuroectodermal Tumors, Primitive; Pharmacology; Research; Toxicology | 1964 |
ON THE CONCENTRATING DEFECT IN CIRRHOSIS OF THE LIVER.
Topics: Alcoholism; Arthritis; Arthritis, Rheumatoid; Coronary Disease; Dehydration; Dermatitis; Diabetes Mellitus; Diuresis; Humans; Inulin; Kidney Diseases; Kidney Function Tests; Liver Cirrhosis; Lung Diseases; Mannitol; Neoplasms; Obesity; Peripheral Nervous System Diseases; Photometry; Potassium; Sodium; Urea; Urine | 1964 |
THE EFFECT OF GLUCOSE PRETREATMENT ON THE ANTI-TUMOUR ACTION OF MANNITOL MYLERAN.
Topics: Anuria; Arginine Vasopressin; Blood; Busulfan; Chromatography; Colorimetry; Fluids and Secretions; Glucose; Hypertonic Solutions; Mannitol; Metabolism; Neoplasms; Pharmacology; Rats; Research; Sodium Chloride; Sorbitol; Triethylenemelamine; Urine; Vasopressins | 1964 |
[ON THE EFFECT OF GLUCOSE ON THE TOXIC AND THERAPEUTIC EFFECTS OF 1,6-DIBROMO-1,6-D-DIDESOXYMANNITOL IN ANIMAL EXPERIMENTS].
Topics: Aminopterin; Animal Experimentation; Animals; Antineoplastic Agents; Busulfan; Carcinoma, Ehrlich Tumor; Dactinomycin; Glucose; Mannitol; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma 37; Sarcoma, Yoshida; Toxicology | 1964 |
[TUMOR INHIBITORY, HEMATOLOGICAL AND TOXICOLOGICAL EFFECTS OF 1,6-DIBROMO-1,6-DIDESOXY-D-MANNITOL].
Topics: Antineoplastic Agents; Busulfan; Hematopoiesis; Kidney; Liver; Mannitol; Mice; Neoplasm Transplantation; Neoplasms; Pharmacology; Rats; Research; Toxicology | 1964 |
NITROGEN MUSTARD-RESISTANT YOSHIDA SARCOMA AND CROSS-RESISTANCE STUDIES.
Topics: Animals; Cyclophosphamide; Mannitol; Mannomustine; Mechlorethamine; Neoplasm Transplantation; Neoplasms; Nitrogen Mustard Compounds; Pharmacology; Rats; Research; Sarcoma; Sarcoma, Yoshida; Thymine | 1965 |
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.
Topics: Antibodies; Antigens, Neoplasm; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cross-Priming; Epitopes, B-Lymphocyte; Humans; Immunotherapy; Mannitol; Membrane Proteins; Neoplasms; Oleic Acids; Oligodeoxyribonucleotides; Recombinant Proteins; Th1 Cells; Vaccination | 2007 |
Determination of polyols in serum by selected ion monitoring.
Topics: Candidiasis; Erythritol; Galactitol; Gas Chromatography-Mass Spectrometry; Humans; Kidney Diseases; Mannitol; Neoplasms; Reference Values; Ribitol; Sorbitol; Sugar Alcohols; Xylitol | 1984 |
Safe and effective two-hour outpatient regimen of hydration and diuresis for the administration of cis-diamminedichloroplatinum (II).
Topics: Adult; Aged; Ambulatory Care; Cisplatin; Diuresis; Female; Fluid Therapy; Furosemide; Humans; Male; Mannitol; Middle Aged; Neoplasms; Uremia | 1981 |
Neoplastic transformation of human cells in culture associated with deficient repair of light-induced chromosomal DNA damage.
Topics: Caffeine; Cell Cycle; Cell Transformation, Neoplastic; Cells, Cultured; Chromatids; DNA Repair; Humans; Light; Mannitol; Neoplasms | 1982 |
Photobleaching of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors.
Topics: Animals; Antineoplastic Agents; Aspartic Acid; Azides; Deuterium; Humans; Mannitol; Metronidazole; Molecular Structure; Neoplasms; Paraquat; Photochemistry; Photochemotherapy; Photosensitizing Agents; Porphyrins; Solvents | 1993 |
pH in human tumour xenografts: effect of intravenous administration of glucose.
Topics: Animals; Breast Neoplasms; Female; Gastrointestinal Neoplasms; Glucose; Humans; Hydrogen-Ion Concentration; Hyperglycemia; Injections, Intravenous; Lung Neoplasms; Male; Mannitol; Neoplasm Transplantation; Neoplasms; Rats; Rats, Inbred Strains; Sarcoma; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured | 1993 |
Addition of both platelets and thrombin in combination accelerates tumor cells to adhere to endothelial cells in vitro.
Topics: Adult; Blood Platelets; Catalase; Cell Adhesion; Endothelium, Vascular; HeLa Cells; Hirudins; Humans; Mannitol; Neoplasms; Superoxide Dismutase; Thrombin; Tumor Cells, Cultured; Umbilical Veins | 1997 |
Safe, rapid administration schedule for cis-platinum-mannitol.
Topics: Adult; Aged; Cisplatin; Creatinine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kidney Tubular Necrosis, Acute; Male; Mannitol; Middle Aged; Neoplasms | 1978 |
The renal pathology in clinical trials of cis-platinum (II) diamminedichloride.
Topics: Acute Kidney Injury; Adult; Aged; Blood Urea Nitrogen; Cisplatin; Creatinine; Drug Evaluation; Epithelium; Female; Humans; Kidney; Kidney Tubular Necrosis, Acute; Kidney Tubules, Distal; Lymphoma; Male; Mannitol; Middle Aged; Neoplasms | 1977 |
High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.
Topics: Adenocarcinoma; Adult; Aged; Cisplatin; Creatinine; Diuresis; Dysgerminoma; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Hearing; Humans; Infusions, Parenteral; Injections, Intravenous; Kidney; Lung Neoplasms; Male; Mannitol; Middle Aged; Neoplasms; Ovarian Neoplasms; Testicular Neoplasms | 1977 |
Drug targeting to the lungs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Adhesion; Dimethyl Sulfoxide; Doxorubicin; Ferric Compounds; Hematoporphyrin Derivative; Hematoporphyrins; Lung; Lung Neoplasms; Magnetics; Mannitol; Microcirculation; Microspheres; Models, Biological; N-Formylmethionine Leucyl-Phenylalanine; Neoplasms; Oligopeptides; Pharmaceutical Preparations; Superoxides | 1986 |
Intestinal permeability during chemotherapy for childhood tumours.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Disaccharides; Female; Humans; Intestinal Absorption; Intestinal Mucosa; Lactulose; Male; Mannitol; Neoplasms; Nutritional Status; Permeability | 1988 |
[Administration of high doses of cisplatin in 20-minute infusions].
Topics: Cisplatin; Fluid Therapy; Furosemide; Humans; Infusions, Intravenous; Kidney Diseases; Mannitol; Neoplasms; Saline Solution, Hypertonic | 1988 |
Tentative clinical application of tetramezyl-mannitol (R52).
Topics: Breast Neoplasms; Female; Hematopoiesis; Humans; Leukemia; Lung Neoplasms; Male; Mannitol; Neoplasms; Palliative Care | 1967 |
[Clinical assay of tetramesyl-mannite therapy of neoplasms].
Topics: Antineoplastic Agents; Carcinoma; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mannitol; Neoplasms | 1970 |
[Physiopathology and treatment of hyponatremia (II)].
Topics: Adrenal Insufficiency; Aldosterone; Anesthesia; Diuretics; Heart Diseases; Humans; Hyperpituitarism; Hyponatremia; Liver Cirrhosis; Mannitol; Neoplasms; Nephritis | 1968 |